Placebo + Xolair
ApprovedUNKNOWN 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Allergy
Conditions
Allergy
Trial Timeline
Jun 1, 2007 → Nov 1, 2012
NCT ID
NCT00673218About Placebo + Xolair
Placebo + Xolair is a approved stage product being developed by Novartis for Allergy. The current trial status is unknown. This product is registered under clinical trial identifier NCT00673218. Target conditions include Allergy.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00673218 | Approved | UNKNOWN |
| NCT00691873 | Approved | Completed |
| NCT00139152 | Approved | Completed |
Competing Products
20 competing products in Allergy